ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

LIGAND PHARMACEUTICALS INC

Sector: —

Biopharma royalty and drug-platform company

2 listed classes/securities ($LGND, $LGNDZ) are filed under this issuer; the holder table aggregates all of them.

Securities filed under this name

Each row is a distinct security a 13F manager filed under this issuer name; the title of class is what identifies it. Click a ticker for its own page.

TickerTitle of classCUSIPSectorFilersValue
unmappedNOTE 0.750%10/053220KAH1—1$36,089,554
$LGND NASDAQCOM NEW53220K504health2$8,047,588
$LGNDZ NASDAQCOM53220K215health1$20

4 tracked filer(s) hold this · 2 opened, 1 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 62 — mean of 4 scored holder(s) · buyers (new/add) avg 68. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275New buy21,500,000$36,089,5540.0%
Bridgewater55New buy9,763$3,049,6680.0%
Steve Cohen / Point7275Added +1900%16,000$4,997,9200.0%
Ancora42Holds (flat)12,000$200.0%

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.